It is March and spring is upon us. Wisconsinites are anticipating the moment they can throw open their windows to feel a rush of fresh, warm-ish air. But March means more than warming weather, March is Colorectal Cancer Awareness Month.
Did you know Colorectal Cancer (CRC) is the most preventable—yet least prevented—form of cancer? Simply understanding your risks for Colorectal Cancer can be your strongest weapon in treatment or diagnosis:
- It is a rising risk in individuals between 45-49 years
- Colorectal Cancer is the third most common cancer in men and women
- Early-stage Colorectal Cancer is often undetected due to a lack of symptoms
- Lifestyle choices such as smoking and alcohol use, lack of exercise and low fiber diets are all risk factors for colon cancer
That is why the best thing you can do for your health is early disease detection through preventive measures such as colorectal cancer screening. And WEA Trust is here to make it easy for you.
Colorectal Cancer Screening Tests
At WEA Trust, we offer Cologuard screening tests for members over 45 years of age , at no cost to the member. However, only your medical provider can recommend if Cologuard is right for you.
Once a provider recommends and orders Cologuard, the screening test is sent to your house for easy and safe use in the comfort of your own home. No special diet, no bowel preparation and no need to take off work.
Cologuard works by detecting abnormal findings in a stool sample and is over 90% accurate in detecting colorectal cancer in early- to late-stage progression. It is approved by the American Cancer Society, U.S. Preventive Services Task Force and National Comprehensive Cancer Network.
For more information about how to obtain a referral for a Colorectal Cancer screening, speak with your provider. To find a provider in your area, please visit the Find-a-Doctor online provider tool.
 One test, every 3 years for adults with average risk for Colorectal Cancer
(Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guidelines update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-281.)
 About Cologuard, High sensitivity in a noninvasive colorectal cancer (CRC) screening option